Wellness Articles

Vaccines, Depression and Neurodegeneration After Age 50: Another Reason to Avoid the Recommended Vaccines.

By Russell L. Blaylock, M.D., CCN

It has been estimated that 14.8 million Americans suffer from major depressive disorder and of this number 6 million are elderly. If we include anxiety disorders, which commonly accompany depression, the number jumps to 40 million adults.

Depression later in life tends to last longer and be more severe than at younger ages. It is also associated with a high rate of suicide. Previously, it was thought that major depression was secondary to a deficiency in certain neurotransmitters in the brain, particularly the monoamines, which include serotonin, norepinephrine and dopamine.

While alterations in these important mood-related neurotransmitters is found with major depression, growing evidence indicates that the primary culprit is low-grade, chronic brain inflammation.

This exclusive article will review in detail the functions and impact of various agents on depression and neurodegeneration, including:

The impact of MSG on your brain and mood
The link between elevated brain glutamate and inflammation
The connections between pesticides and neurological disorders such as Alzheimer’s and Parkinson’s disease
How vaccinations cause brain inflammation
The impact of an expanding vaccine schedule for the elderly
The shocking truth, linking brain inflammation to neurodegenerative diseases
How vaccine additives such as mercury and aluminum impact your brain health
The real danger of live virus vaccines
Current recommendations by the CDC for adult vaccinations include a total of 14 separate inoculations with infectious agents and powerful immune adjuvants.

According to CDC recommendations, multiple vaccinations for a single disease are separated by no more than 4 weeks, which is close enough together to trigger a smoldering process of brain inflammation and excitotoxicity that can not only result in depression, anxiety and high suicide rates, but can increase your risk of developing one of the neurodegenerative diseases as well.

We have also seen that in many cases a person will be injected with several vaccines during a single office visit and this means that their body is exposed to a very large dose of immune adjuvant. Compelling studies, using many animal species as well as humans, have shown that this overactivates brain inflammatory mechanisms that can last for years.

I urge you to read Dr. Blaylock’s full-length article, Vaccines, Depression and Neurodegeneration After Age 50: Another Reason to Avoid the Recommended Vaccines, a Mercola.com exclusive, for a fascinating in-depth look at how neurodegenerative diseases are created, and how to protect yourself from what many consider to be simply side effects of the ravages of time — but are anything but a natural byproduct of aging.

Contributed by: Dr. Aaron on February 26, 2008   ·  Filed under: Information and Research  ·  

If you have been to any of our talks than this should come as no surprise to you. I have been talking about this kind of stuff at our Chiropractic Clinic called Discover Chiropractic in Beaverton Oregon for years. If you review the available research, the fact that most drugs don’t work as expected is not the real issue, but that these drugs cause very serious side effects. The scariest thing I have seen prozac linked to is the school shootings that have happened over the past years. From reports, all of the school shooters were on prozac, ritalin or another version of these drugs.

Prozac, used by 40m people, does not work say scientists
Analysis of unseen trials and other data concludes it is no better than placebo
Full text: the PLoS paper
Sarah Boseley, health editor The Guardian, Tuesday February 26 2008 Article history · Contact us Contact usClose Contact the Society editor
editor@societyguardian.co.uk Report errors or inaccuracies: reader@guardian.co.uk Letters for publication should be sent to: letters@guardian.co.uk If you need help using the site: userhelp@guardian.co.uk Call the main Guardian and Observer switchboard:
+44 (0)20 7278 2332
Advertising guide License/buy our content About this articleClose This article appeared in the Guardian on Tuesday February 26 2008 on p1 of the Top stories section. It was last updated at 09:56 on February 26 2008.
A single Prozac capsule. Photograph: Alamy

Prozac, the bestselling antidepressant taken by 40 million people worldwide, does not work and nor do similar drugs in the same class, according to a major review released today.

The study examined all available data on the drugs, including results from clinical trials that the manufacturers chose not to publish at the time. The trials compared the effect on patients taking the drugs with those given a placebo or sugar pill.

When all the data was pulled together, it appeared that patients had improved - but those on placebo improved just as much as those on the drugs.

The only exception is in the most severely depressed patients, according to the authors - Prof Irving Kirsch from the department of psychology at Hull University and colleagues in the US and Canada. But that is probably because the placebo stopped working so well, they say, rather than the drugs having worked better.

“Given these results, there seems little reason to prescribe antidepressant medication to any but the most severely depressed patients, unless alternative treatments have failed,” says Kirsch. “This study raises serious issues that need to be addressed surrounding drug licensing and how drug trial data is reported.”

The paper, published today in the journal PLoS (Public Library of Science) Medicine, is likely to have a significant impact on the prescribing of the drugs. The National Institute for Health and Clinical Excellence (Nice) already recommends that counselling should be tried before doctors prescribe antidepressants. Kirsch, who was one of the consultants for the guidelines, says the new analysis “would suggest that the prescription of antidepressant medications might be restricted even more”.

The review breaks new ground because Kirsch and his colleagues have obtained for the first time what they believe is a full set of trial data for four antidepressants.

They requested the full data under freedom of information rules from the Food and Drug Administration, which licenses medicines in the US and requires all data when it makes a decision.

The pattern they saw from the trial results of fluoxetine (Prozac), paroxetine (Seroxat), venlafaxine (Effexor) and nefazodone (Serzone) was consistent. “Using complete data sets (including unpublished data) and a substantially larger data set of this type than has been previously reported, we find the overall effect of new-generation antidepressant medication is below recommended criteria for clinical significance,” they write.

Two more frequently prescribed antidepressants were omitted from the study because scientists were unable to obtain all the data.

Concerns have been raised in recent years about the side-effects of this class of antidepressant. Evidence that they could prompt some young people to consider suicide led to a warning to doctors not to prescribe them for the under-18s - with the exception of Prozac, which was considered more effective than the rest.

In adults, however, the depression-beating benefits were thought to outweigh the risks. Since its launch in the US in 1988, some 40 million people have taken Prozac, earning tens of billions of dollars for the manufacturer, Eli Lilly. Although the patent lapsed in 2001, fluoxetine continues to make the company money - it is now the active ingredient in Sarafem, a pill sold by Lilly for premenstrual syndrome.

Eli Lilly was defiant last night. “Extensive scientific and medical experience has demonstrated that fluoxetine is an effective antidepressant,” it said in a statement. “Since its discovery in 1972, fluoxetine has become one of the world’s most-studied medicines. Lilly is proud of the difference fluoxetine has made to millions of people living with depression.”

A spokesman for GlaxoSmithKline, which makes Seroxat, said the authors had failed to acknowledge the “very positive” benefits of the treatment and their conclusions were “at odds with what has been seen in actual clinical practice”.

He added: “This analysis has only examined a small subset of the total data available while regulatory bodies around the world have conducted extensive reviews and evaluations of all the data available, and this one study should not be used to cause unnecessary alarm and concern for patients.”

Contributed by: Dr. Aaron on   ·  Filed under: portland oregon chiropractic, Information and Research  ·  

MONTEL WILLIAMS: HEALED BY CHIROPRACTIC

While I was on vacation last week, it seemed like almost every day there was some positive report about Chiropractic in the news. There was a report about how much headaches and migraines were helped with Chiropractic. Also there was the report about how people with high blood pressure were having their blood pressure normalized by removing spinal misalignments in the neck. Then I saw this with Montel Williams. This is stuff we see all the time in our practice, but its nice to see it in the mainstream media as well.

Popular talk show host Montel Williams is singing the praises of chiropractic adjustments. This comes after a nearly instantaneous recovery from pain upon receiving his first chiropractic treatment.

After years of rough scholastic sports, adult boxing and martial arts training, Montel Williams, now age 51, was diagnosed with Multiple Sclerosis. The diagnosis came after he sought medical treatment for severe pain in his legs and feet that lasted 24-hours a day, 7-days a week, 365 days year. The pain was so severe that often times Williams could not stand up straight. In attempts to lessen the pain in his feet, Williams would shift his weight from leg to leg. Something had to be done.

That’s when Williams met Patrick Kerr, Doctor of Chiropractic.

Doctor Kerr began by taking X-rays of Williams spine, focusing attention on the neck and how the head sat on the neck. X-rays confirmed that Williams was suffering with a severe misalignment of the Atlas vertebrae—the vertebrae at the very top of the spine that supports the head. This misalignment was putting pressure on nerves that lead from the brain stem. In short, the misaligned Atlas vertebrae was interfering with brain messages and causing pain in Williams’ legs and feet.

Using a special machine called the Atlas Orthogonal, Doctor Kerr gave Williams a very precise, and completely pain-free chiropractic adjustment to the Atlas vertebrae. By moving this vertebra back into proper alignment, brain messages sent through the spinal cord were no longer blocked, and nerve pressure was relieved. This allowed the body to send proper messages to Williams’ legs and feet, instead of sending messages of pain.

“It’s the most amazing thing that has ever happened to me!” says Williams. “I experienced almost instantaneous relief from pain with my first adjustment.”

Misalignment of the spine is often associated with trauma, such as car accidents (big or small), sports injuries, and slips and falls. But the danger doesn’t stop there. Bad sleeping habits, incorrect lifting and carrying, and even poor posture can—over time—cause spinal misalignments.

That’s why it’s so important to schedule regular chiropractic adjustments. If you don’t currently experience physical pain or discomfort, chiropractic adjustments can be used as a preventative measure. If you already experience frequent discomfort, ask your doctor of chiropractic for a complete spinal examination and a treatment schedule that will put you on your way to an improved quality of life.

To view Montel Williams’ complete chiropractic testimony, visit You Tube: http://www.yourspine.com/NewsResearch/Montel%20Williams.aspx

Contributed by: Dr. Aaron on February 21, 2008   ·  Filed under: Information and Research  ·